Literature DB >> 3086422

Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.

R Paradisi, S Venturoli, R Pasquali, M Capelli, E Porcu, R Fabbri, C Flamigni.   

Abstract

To investigate the interrelationships between body weight and gonadotropin secretion of polycystic ovarian disease (PCO), basal hormonal pattern and responses of gonadotropins and 17 beta estradiol (E2) to 25 micrograms (bolus) and 175 micrograms (4-h infusion) of synthetic luteinizing hormone-releasing hormone (LHRH) were studied in two age-matched groups of 18 obese (OB-PCO) and 18 normal-weight (NO-PCO) women suffering from the syndrome. Unlike other hormone levels, plasma LH and the LH/FSH ratio values were significantly higher (p less than 0.001) in NO-PCO than in OB-PCO females. Moreover, LH response to both stimuli was significantly greater in NO-PCO with respect to OB-PCO. No differences were found in FSH response, whereas E2 response was significantly higher (p less than 0.05) in the NO-PCO group during the continuous infusion test. These results emphasize the role of body weight in the development of PCO in obese females.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086422     DOI: 10.1007/BF03348085

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  The polycystic ovary. I. Clinical and histologic features.

Authors:  J W GOLDZIEHER; J A GREEN
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

2.  The functional changes of the pituitary gonadotrophs during the menstrual cycle.

Authors:  C F Wang; B L Lasley; A Lein; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

3.  [Hypothalamic -hypophyseal functional activity in amenorrhea. Comparison between GnRH stimulation response and the results of discriminative analysis of basal hormonal levels].

Authors:  S Venturoli; R Paradisi; L Gammi; V M Jasonni; C Flamigni
Journal:  Ann Ostet Ginecol Med Perinat       Date:  1980 Sep-Oct

4.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

Authors:  R Rebar; H L Judd; S S Yen; J Rakoff; G Vandenberg; F Naftolin
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome.

Authors:  J Wortsman; W B Wehrenberg; J R Gavin; J P Allen
Journal:  Obstet Gynecol       Date:  1984-05       Impact factor: 7.661

6.  Pituitary response to bolus and continuous intravenous infusion of luteinizing hormone-releasing factor in normal women and women with polycystic ovarian syndrome.

Authors:  R H Mortimer; M Lev-Gur; R Freeman; N Fleischer
Journal:  Am J Obstet Gynecol       Date:  1978-03-15       Impact factor: 8.661

7.  Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

Authors:  R Pasquali; F Casimirri; S Venturoli; R Paradisi; L Mattioli; M Capelli; N Melchionda; G Labò
Journal:  Acta Endocrinol (Copenh)       Date:  1983-09

8.  Obesity and its role in polycystic ovary syndrome.

Authors:  S R Plymate; B L Fariss; M L Bassett; L Matej
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

9.  Ultrasonic findings in polycystic ovarian disease.

Authors:  L F Orsini; S Venturoli; R Lorusso; V Pluchinotta; R Paradisi; L Bovicelli
Journal:  Fertil Steril       Date:  1985-05       Impact factor: 7.329

10.  Radioimmunoassay of three oestrogens and three androgens in the same plasma sample after extraction and chromatographic separation.

Authors:  R Paradisi; S Lodi; G Bolelli; S Venturoli
Journal:  Acta Endocrinol (Copenh)       Date:  1980-06
View more
  4 in total

Review 1.  Functional significance of the innervation of the gonads.

Authors:  Ida Gerendai; Péter Banczerowski; Béla Halász
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Hyperandrogenism, hyperinsulinism and polycystic ovarian disease.

Authors:  R Pasquali; S Venturoli
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

3.  Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.

Authors:  R Pasquali; D Antenucci; F Casimirri; S Venturoli; R Paradisi; R Fabbri; N Melchionda; L Barbara
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

Review 4.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.